COST-EFFECTIVENESS OF TRANSFERRING TYPE 2 DIABETIC PATIENTS FROM NEUTRAL PROTAMINE HAGEDORN (NPH) TO DETEMIR IN PORTUGAL SETTINGS

被引：0
|
作者：
Carvalho, D. [1 ]
Lindner, L. [2 ]
Kozarzewski, M. [3 ]
机构：
[1] Sao Joao Hosp, Oporto, Portugal
[2] IMS Hlth, Barcelona, Cataluna, Spain
[3] Novo Nordisk Portugal, Lisbon, Portugal
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1348
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A479 / A480
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Portugal
    Cardoso, Cristina
    Ramirez de Arellano, Antonio
    Prades, Miriam
    Lizan, Luis
    [J]. JOURNAL OF DIABETES & METABOLISM, 2016, 7 (03)
  • [2] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
    Morales, Cristobal
    de Luis, Daniel
    Ramirez de Arellano, Antonio
    Giovanna Ferrario, Maria
    Lizan, Luis
    [J]. DIABETES THERAPY, 2015, 6 (04) : 593 - 610
  • [3] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
    Cristóbal Morales
    Daniel de Luis
    Antonio Ramírez de Arellano
    Maria Giovanna Ferrario
    Luis Lizán
    [J]. Diabetes Therapy, 2015, 6 : 593 - 610
  • [4] SHORT-TERM COST-EFFECTIVENESS ANALYSIS OF INSULIN DETEMIR VERSUS INSULIN NEUTRAL PROTAMINE HAGEDORN (NPH) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN SPAIN
    Ramirez de Arellano, A.
    Morales, C.
    De Luis, D.
    Ferrario, M. G.
    Lizan, L.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A343 - A343
  • [5] Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach
    Pollock, Richard F.
    Chubb, Barrie
    Valentine, William J.
    Heller, Simon
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2018, 11 : 217 - 226
  • [6] Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis
    E. Lau
    A. Salem
    J. C. N. Chan
    W. Y. So
    A. Kong
    M. Lamotte
    A. Luk
    [J]. Cost Effectiveness and Resource Allocation, 17
  • [7] Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis
    Lau, E.
    Salem, A.
    Chan, J. C. N.
    So, W. Y.
    Kong, A.
    Lamotte, M.
    Luk, A.
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2019, 17 (1)
  • [8] Cost-effectiveness of detemir versus NPH for type 1 diabetes patients treated with basal-bolus therapy in Portugal
    Silva, C.
    Alves, C.
    Negreiro, F.
    Fonseca, M. A.
    Aagren, M.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A227 - A227
  • [9] LONG-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR COMPARED TO NEUTRAL PROTAMINE HAGEDORN INSULIN IN PATIENTS WITH TYPE 1 DIABETES USING A BASAL-BOLUS REGIMEN IN SWEDEN
    Valentine, W. J.
    Lammert, M.
    Aagren, M.
    Gschwend, M. H.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A503 - A503
  • [10] Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
    Unchalee Permsuwan
    Nathorn Chaiyakunapruk
    Piyameth Dilokthornsakul
    Kednapa Thavorn
    Surasak Saokaew
    [J]. Applied Health Economics and Health Policy, 2016, 14 : 281 - 292
12345